A vape can appear on an official Australian list without being TGA-approved. So, What Is a TGA-Notified Vape? In plain English, it is a therapeutic vaping good that its sponsor has notified to the Therapeutic Goods Administration for possible lawful supply.
That notification can be misleading, though. It does not mean the TGA has tested, approved, or endorsed the product. Adults, caregivers, pharmacists, and prescribers often find this point confusing, so it helps to separate “notified” from “approved” before anyone buys, prescribes, or supplies a vape.
Accuracy note: Regulations checked as of September 2026. This guide provides general information only. It is not personal medical advice or legal advice.
What Is a TGA-Notified Vape?
A TGA-notified vape is a therapeutic vaping good that its sponsor has notified to the Therapeutic Goods Administration. The sponsor is usually the Australian business responsible for importing, manufacturing, or supplying the product. In short, the sponsor tells the TGA the product meets relevant Australian requirements.
In practice, notification works like a formal declaration. The sponsor declares compliance before lawful importation, manufacture, or supply. But the TGA does not automatically assess each notified vape in the same way it assesses a fully approved medicine.
Therapeutic vaping goods cover several product types. A notified product may be a vaping substance, device, kit, pack, accessory, or another related therapeutic good. These products must also relate to smoking cessation or nicotine dependence management.
- Vaping substances, such as liquids or pods
- Vaping devices used with therapeutic vaping substances
- Kits, packs, cartridges, and accessories
- Other related goods covered by Australian vaping rules
The main thing to remember is simple: “TGA-notified” does not mean “TGA-approved.” It also does not mean the product is registered or listed on the Australian Register of Therapeutic Goods. You can read the TGA’s central guidance through the official TGA vaping hub.
Think of notification as an entry gate, not a gold medal. A sponsor has made a compliance declaration. That declaration does not prove the product is safe, effective, or suitable for a particular person.
TGA-Notified vs TGA-Approved: The Key Difference
The key difference is independent assessment. TGA-approved products on the Australian Register of Therapeutic Goods have gone through a formal regulatory process. By contrast, most therapeutic nicotine vapes are still unapproved therapeutic goods.
But “unapproved” does not always mean unlawful. It means the product has not gone through the usual approval process for registration or listing. Supply therefore has to happen through specific access pathways.
A notified vape may appear on the notified vape list because its sponsor declared compliance with required standards. Still, the TGA warns that notified vapes have not been assessed for safety, quality, efficacy, or performance. That warning matters for consumers and health professionals alike.
Picture two products sitting behind a pharmacy counter. One medicine appears on the ARTG after TGA assessment. A therapeutic vape, meanwhile, may be notified but still supplied as an unapproved therapeutic good.
This is where many people get caught. They see “TGA” beside a vape and assume it means approval. It does not. Appearing on the notified vape list does not mean the product passed independent TGA testing.
Therapeutic nicotine vapes are also not regulated exactly like medicinal cannabis vaping devices. The TGA treats cannabis vaping devices under separate rules, so pharmacists and prescribers should be careful not to blur the two categories when giving advice.
For broader legal background, readers may also compare this topic with Australian vape laws. The core point remains straightforward. Notification supports lawful therapeutic supply, but it does not equal approval.
Are TGA-Notified Vapes Legal in Australia?
TGA-notified vapes can be legal in Australia, but only in the right setting. Lawful consumer access is centred on Australian pharmacies. The supply must support smoking cessation or nicotine dependence management.
Notification status alone does not make every sale legal. The seller, patient, purpose, product type, nicotine strength, and state rules all matter. A legal product can still be supplied unlawfully if the wrong seller provides it.
The TGA states that vapes cannot be supplied through non-pharmacy retail stores. That includes tobacconists, vape shops, convenience stores, and many general retailers. Pharmacy-only supply is one of the central features of the Australian framework.
Online sales need a careful look, too. A website may describe a vape as therapeutic, nicotine-free, or TGA-notified. Those words do not automatically make the sale lawful.
Nicotine-free vapes cause plenty of confusion. Many buyers assume zero nicotine means unrestricted retail sale. Under Australian rules, though, zero-nicotine vaping goods are still restricted through pharmacies.
For example, a corner shop selling “nicotine-free wellness vapes” may still be breaching the rules. The label does not decide the legal pathway. Buyers need to check the source, not just the claim.
The TGA also warns about unlawful supply and advertising. Advertising restrictions are strict because vapes remain tightly controlled therapeutic goods. The safest step is to speak with a registered pharmacist or prescriber before buying.
How Can Patients Access Therapeutic Vapes Australia?
Pharmacy Access for Adults
Adults may access therapeutic vapes through Australian pharmacies when clinically appropriate. The purpose must be smoking cessation or nicotine dependence treatment. Even then, a pharmacist needs to assess suitability before supply.
For adults aged 18 and over, some Schedule 3 therapeutic vapes may be supplied without a prescription. This generally applies where nicotine concentration is 20 mg/mL or less. State and territory rules can still add further limits.
The pharmacist must consider the person’s needs, risks, alternatives, and intended use. They may ask about smoking history, past quit attempts, medicines, pregnancy, mental health, or heart conditions. So yes, the conversation may feel more like a health consultation than a retail purchase.
Pharmacists can also provide advice on quit smoking options. Approved options may include behavioural support, nicotine replacement therapy, varenicline, or other evidence-based treatments. In many cases, those choices come before vaping.
When a Prescription May Be Required
A prescription may be required in several situations. Schedule 4 therapeutic vapes with nicotine above 20 mg/mL, for example, need a prescription. Vapes above 50 mg/mL are not permitted.
People under 18 also need a prescription where supply is allowed. Some states and territories may prohibit supply to minors even with a prescription, so local rules must be checked before any pharmacist dispenses.
Prescriptions can come from medical practitioners or nurse practitioners. The prescriber must use an appropriate access pathway for unapproved therapeutic goods. Put simply, the pathway provides the legal basis for supply.
SAS and Authorised Prescriber Pathways
The Special Access Scheme helps patients access certain unapproved therapeutic goods. In this context, it can support lawful supply of therapeutic vaping goods. You can learn the basics through this guide to the Special Access Scheme.
The Authorised Prescriber pathway works differently. It allows approved prescribers to prescribe specified unapproved therapeutic goods without seeking separate approval for every patient. The prescriber still has to meet the pathway conditions.
For pharmacy practice, the TGA explains supply rules in its guidance on supplying therapeutic vapes in pharmacies. The Pharmaceutical Society of Australia also provides practical support through its vaping reforms guidance.
The Notified Vape List, TGO 110, and Product Standards
How the Notified Vape List Works
The notified vape list helps pharmacists, prescribers, and regulators identify products declared for therapeutic supply. It lists therapeutic vaping goods for smoking cessation or nicotine dependence management. Even so, users should treat the list with care.
A product can appear because a sponsor notified it as compliant with applicable standards. That does not mean the TGA has assessed the product like an approved medicine. Checking the list is necessary, but it is not the only check that matters.
Patients and professionals can use the TGA vaping hub to find the notified vape list. Checking the list before taking action is one of the most practical safety steps. Product status can also change if compliance problems arise.
What TGO 110 Covers
TGO 110 is the product standard for many unapproved therapeutic vaping products. In plain English, it sets rules for what these products can contain and how they must appear. It also covers packaging, labels, ingredients, and related conditions.
The standard restricts ingredients and flavours. Permitted flavours are generally limited to mint, menthol, and tobacco. Nicotine concentration limits also apply, and products above 50 mg/mL are not permitted.
Plain packaging matters as well. Australia does not treat therapeutic vapes like colourful lifestyle products. Labels and packaging must avoid youth appeal, misleading presentation, and non-therapeutic promotion.
- Ingredient restrictions, including nicotine and carrier ingredients
- Nicotine concentration limits and quality requirements
- Plain packaging and required labelling information
- Restricted flavours, such as mint, menthol, and tobacco
- Rules that support pharmacy supply and professional oversight
Device and Safety Expectations
Device-related expectations may also apply. Vaping devices and accessories may need to meet medical device standards. Regulators look at safety, quality, compatibility, and appropriate use with therapeutic substances.
For example, a device should work reliably with the intended pod or liquid. Battery safety matters too, because poor devices can overheat or fail. Pharmacists should not treat these devices as ordinary consumer electronics.
Australian Pharmacist has also explained practical changes under the standards. Its professional coverage of the new vaping standards gives useful context for pharmacy teams. Official TGA guidance, however, should remain the primary reference.
Common Misunderstandings About TGA-Notified Vapes
Misunderstandings spread quickly because the rules use technical language. The main myths, though, are not hard to unpack. A notified vape is not automatically safe, approved, or freely available.
- Myth: TGA-notified means the TGA tested and approved the vape. In fact, notified vapes have not been assessed by the TGA for safety, quality, efficacy, or performance.
- Myth: nicotine-free vapes are freely available outside pharmacies. However, zero-nicotine vaping goods are still restricted under Australian vaping rules.
- Myth: any vape sold online is legal if it claims to be therapeutic. Therefore, buyers should check the seller, pathway, product status, and pharmacy involvement.
- Myth: vapes are recommended as first-line smoking cessation treatment. In fact, first-line support usually includes behavioural help and approved pharmacotherapies.
- Myth: therapeutic nicotine vapes are regulated like medicinal cannabis vaping devices. However, medicinal cannabis vaping devices sit under separate TGA guidance.
For instance, someone may search online after several failed quit attempts. They find a site promising a “TGA-notified therapeutic vape” with fast shipping. That claim still does not prove lawful supply or clinical suitability.
Health professionals should also watch for misleading advertising. Vape promotion faces heavy restrictions in Australia. Strong therapeutic claims, lifestyle imagery, and youth-friendly presentation can all raise serious compliance concerns.
What Patients, Pharmacists, and Prescribers Should Check
Patients
Patients should begin with a health conversation, not a product search. Ask a pharmacist, doctor, or nurse practitioner about suitability, risks, alternatives, nicotine strength, and lawful access. It is also worth asking whether approved treatments may suit you better.
Some people may do better with nicotine patches, gum, counselling, or prescription medicines. Others may need extra support because of pregnancy, heart disease, or mental health concerns. Personal advice matters here.
Pharmacists
Pharmacists should check notification status before supply. They should also verify age, indication, nicotine concentration, product conditions, informed consent, recordkeeping, and state rules. Professional obligations around storage and counselling still apply.
Practical checks include whether the product appears on the notified vape list. The pharmacist should confirm the supply supports smoking cessation or nicotine dependence management. They should also discuss alternatives, dose, treatment length, and warning signs.
Pharmacy teams may also compare this process with pharmacist-only medicines. Therapeutic vapes have extra conditions because they remain unapproved therapeutic goods, so routine retail habits do not fit this category.
Prescribers and Reporting
Prescribers should consider approved smoking cessation treatments first. Where relevant, they should use the correct Special Access Scheme or Authorised Prescriber pathway. Prescriptions should match the patient, product, indication, and applicable rules.
Everyone involved should report problems. Patients, pharmacists, and prescribers can report adverse events, product defects, suspected unlawful supply, and misleading advertising. That helps regulators identify risks faster.
Finally, compare treatment choices carefully. A practical discussion of nicotine replacement therapy vs vaping can help patients understand safer starting points. Above all, no one should rely on a product label alone.
Conclusion
A TGA-notified vape is a therapeutic vaping good whose sponsor has declared compliance with relevant Australian requirements. It is not the same as a TGA-approved product. It has not necessarily been assessed by the TGA for safety, quality, efficacy, or performance.
Legal access in Australia centres on pharmacies, smoking cessation, nicotine dependence management, and professional oversight. Convenience-store sales, casual online purchases, and broad “therapeutic” claims all need careful checking. Notification supports lawful pathways, but it does not replace clinical judgement.
Before buying, prescribing, or supplying a vape in Australia, check the TGA notified vape list. Then speak with a registered pharmacist, doctor, or nurse practitioner about lawful access and safer treatment options.
